ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,447.87
-0.31%
US Tech 100
18,982.40
-1.17%
다우존스 지수
39,411.21
0.67%
Bitcoin
61,003.33
1.21%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Corcept Therapeutics Inc (CORT)

  7. Corcept Therapeutics Inc (CORT) 뉴스

CORT

Corcept Therapeutics (CORT)

Corcept Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:CORT
일자시간출처헤드라인심볼기업
2024/06/2505:15GlobeNewswire Inc.Corcept Announces Presentation of Results From Prevalence Phase of CATALYST Clinical Trial at American Diabetes Association’s Scientific SessionsNASDAQ:CORTCorcept Therapeutics Inc
2024/06/0707:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
2024/06/0610:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
2024/06/0610:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
2024/06/0610:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
2024/06/0610:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
2024/06/0610:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
2024/06/0610:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
2024/06/0403:15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CORTCorcept Therapeutics Inc
2024/06/0403:05Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CORTCorcept Therapeutics Inc
2024/06/0402:05Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CORTCorcept Therapeutics Inc
2024/06/0321:00GlobeNewswire Inc.Corcept Therapeutics Announces Presentations of Results of Pivotal Phase 3 GRACE Trial Evaluating Relacorilant in Patients with Hypercortisolism (Cushing’s Syndrome)NASDAQ:CORTCorcept Therapeutics Inc
2024/06/0105:47Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
2024/06/0105:46Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
2024/06/0105:45Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
2024/06/0105:44Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
2024/06/0105:43Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
2024/06/0105:41Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
2024/06/0105:40Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
2024/06/0105:39Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
2024/06/0105:38Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
2024/06/0105:38Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
2024/06/0105:38Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CORTCorcept Therapeutics Inc
2024/06/0105:01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CORTCorcept Therapeutics Inc
2024/05/3110:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
2024/05/3109:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
2024/05/2908:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CORTCorcept Therapeutics Inc
2024/05/2902:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CORTCorcept Therapeutics Inc
2024/05/2902:14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CORTCorcept Therapeutics Inc
2024/05/2821:00GlobeNewswire Inc.Corcept Announces Primary Endpoint Met in Pivotal Phase 3 GRACE Trial of Relacorilant in Patients With Hypercortisolism (Cushing’s Syndrome)NASDAQ:CORTCorcept Therapeutics Inc
 검색 관련기사 보기:NASDAQ:CORT

최근 히스토리

USOTC
BGGYF
Bill Identity (CE)
ASX
TOK
Tolu Minerals
EU
CABP
Carrefour Domestic bond ...
USOTC
OUTB
Outback Oil and Min Expl (CE)
USOTC
SMFRF
Sumitomo Forestry (PK)
BIT
P1XR79
NLBNPIT1XR79 20351221 1.6
USOTC
CTOBF
China Tobacco Internatio... (GM)
NYSE
SAH
Sonic Automotive
TG
1HI
First Hawaiian
NASDAQ
FSZBX
Fidelity Advisor Sustain...
BIT
SFVS1S
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유